This website is intended for healthcare professionals

Tackling the use of supari (areca nut) and smokeless tobacco products in the south asian community in the united kingdom

    Abstract

    The use of supari (areca nut) and smokeless tobacco products are seen as a major risk factor for oral cancer. There are increasing rates of oral cancer across the United Kingdom, along with the increase of the use of these products. This article examines the uses of such products amongst the South Asian Community and explores sensitive issues associated with the cessation of their use. Evidence-based recommendations are provided on how to provide advice and treatment to patients that regularly use these products. A rethink is also suggested on the policy of taxation of such products.

    CPD/Clinical Relevance: With the rates of oral cancer increasing across the United Kingdom, it is important for us as dental professionals to tackle the use of areca nut and smokeless tobacco products.

    References

    • 1. Cancer Research UK [Internet]. Lung Cancer Incidence Statistics 2015. Available from: www.cancerresearchuk.org/cancer-info/cancerstats/types/lung/incidence/uk-lung-cancer-incidence-statistics Google Scholar
    • 2. Cancer Research UK [Internet]. Oral Cancer Incidence Statistics 2013. Available: www.cancerresearchuk.org/cancer-info/cancerstats/types/oral/incidence Google Scholar
    • 3. Mehanna H, Jones T, Gregoire V, Ang KK. Oropharyngeal carcinoma related to human papillomavirus. Br Med J 2010; 340(10): 1439. Google Scholar
    • 4. Nelson BS, Heischober B. Betel nut: a drug used by naturalized citizens from India, Far East Asia, and the South Pacific Islands. Ann Emerg Med 1999; 34(2): 238–243. MedlineGoogle Scholar
    • 5. Marshall M (Lindstrom L, ed). An overview of drugs in oceania. In: Drugs in Western Pacific Societies: Relations of Substance. ASAO Monograph No. II. Lanham: University Press of America, 1987. Google Scholar
    • 6. Ekanayaka RP, Tilakaratne WM. Oral submucous fibrosis: review on mechanisms of pathogenesis and malignant transformation. J Carcinogene Mutagene 2013; S5: 002. Google Scholar
    • 7. Lewis MAO, Jordan RCK. Oral Medicine: A Colour Handbook 2nd edn. London: BDA, 2012. Google Scholar
    • 8. Chu NS. Effects of Betel chewing on the central and autonomic nervous systems. J Biomed Sci 2001; 8(3): 229–236. MedlineGoogle Scholar
    • 9. Hsu HF, Tsou TC, Chao HR, Shy CG, Kuo YT, Tsai FY et al.. Effects of arecoline on adipogenesis, lipolysis, and glucose uptake of adipocytes – a possible role of betel-quid chewing in metabolic syndrome. Toxicol Appl Pharm 2010; 245(3): 370–377. MedlineGoogle Scholar
    • 10. Taylor RF, Al-Jarad N, John LM, Conroy DM, Barnes NC. Betel-nut chewing and asthma. Lancet 1992; 339(8802): 1134–1136. MedlineGoogle Scholar
    • 11. Senn M, Baiwog F, Winmai J, Mueller I, Rogerson S, Senn N. Betel nut chewing during pregnancy, Madang province, Papua New Guinea. Drug Alcohol Depen 2009; 105(1–2): 126–131. MedlineGoogle Scholar
    • 12. Akhtar S. Areca nut chewing and esophageal squamous-cell carcinoma risk in Asians: a meta-analysis of case-control studies. Cancer Cause Control 2013; 24(2): 257–265. MedlineGoogle Scholar
    • 13. Her Majesty's Government [Internet]. Alcohol and Tobacco Duties 2014. Available from: www.gov.uk/tax-on-shopping/alcohol-tobacco Google Scholar
    • 14. Brennan A, Meng Y, Holmes J, Hill-McManus D, Meier PS. Potential benefits of minimum unit pricing for alcohol versus a ban on below cost selling in England 2014: modelling study. Br Med J 2014; 349(1): 1–14. Google Scholar
    • 15. Croucher R, Awojobi O, Dahiya M. Smokeless Tobacco Scoping Survey of the London Borough of Tower Hamlets. London: Barts and the London School of Medicine and Dentistry, 2009. Google Scholar
    • 16. HM Revenue & Customs and UK Border Agency. Tackling Tobacco Smuggling Together. London: The Stationery Office, 2009. Google Scholar
    • 17. Panesar SS, Gatrad R, Sheikh A. Smokeless tobacco use by South Asian youth in the UK. Lancet 2008; 372(9633): 97–98. MedlineGoogle Scholar
    • 18. Eaton DK, Kann L, Kinchen S, Shaklin S, Ross J, Hawkins J et al.. Youth risk behavior surveillance – United States, 2009. MMWR Surveill Summ 2010; 59(5): 1–142. MedlineGoogle Scholar
    • 19. Eur-Lex. Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2001 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco products – Commission statement. OJ L 194 2001; 0023–0035. Google Scholar
    • 20. Richtel M, Jolly D [Internet]. Studying Snuss, a Smokeless Tobacco From Sweden 2014. Available from: www.nytimes.com/2014/11/30/business/studying-snus-a-smokeless-tobacco-from-sweden.html?_r=1 Google Scholar
    • 21. Ebbert J, Montori VM, Erwin PJ, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev 2011; 16(2): 1–51. Google Scholar
    • 22. National Institute of Health and Care Excellence [Internet]. Smokeless Tobacco Ccessation: South Asian Communities 2012. Available: www.nice.org.uk/guidance/ph39 Google Scholar

    This website is intended for healthcare professionals